Spinal Cord Neoplasm
Back to Diseases List
Associated Genetic Biomarkers
NCI Definition: A primary or metastatic neoplasm affecting the spinal cord. 
There is 1 clinical trial for spinal cord neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains spinal cord neoplasm as an inclusion criterion, 1 is phase 1 (1 open).
RB1 is the most frequent gene inclusion criterion for spinal cord neoplasm clinical trials .
Everolimus and ribociclib are the most common interventions in spinal cord neoplasm clinical trials.
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.